Clinical Significance of MYT1L Gene Polymorphisms in Chinese Patients with Gastric Cancer

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhang, Yangmei ^a,b   Zhu, Haixia ^c,d   Zhang, Xunlei ^a   Gu, Dongying ^a   Zhou, Xichang ^e   Wang, Meilin ^c,d   Cao, Chunxiang ^a   Zhang, Xiaojing ^a   Wu, Xiaomin ^a   Gong, Weida ^f   Tang, Yongfei ^g   Zhou, Jianwei ^c   Tang, Cuiju ^a   Zhang, Zhengdong ^c,d   Chen, Jinfei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Nanjing Medical University   (China)

^e QINGHAI UNIVERSITY   (China)

^f Yixing Cancer Hospital   (China)

^g YIXING PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISTANT METASTASIS; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYT1L GENE; OVERALL SURVIVAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH SURGERY; SURVIVAL TIME; TUMOR VOLUME;

CARDIA; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84883138331     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071979     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E, (2007) Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 94: 737-742.
3. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, et al. (2009) Gastric cancer. Crit Rev Oncol Hematol 71: 127-164.
4. Resende C, Ristimäki A, Machado JC, (2010) Genetic and Epigenetic Alteration in Gastric Carcinogenesis. Helicobacter 15: 34-39.
5. Ludwig JA, Weinstein JN, (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856.
6. Becker KF, Keller G, Hoefler H, (2000) The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11.
7. Klug A, (2010) The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation. Q Rev Biophys 43: 1-21.
8. Matthews JM, Sunde M, Ludwig JA, Weinstein JN, (2002) Zinc Fingers-Folds for Many Occasions. IUBMB Life 54: 351-355.
9. Stevens SJ, van Ravenswaaij-Arts CM, Janssen JW, Klein Wassink-Ruiter JS, van Essen AJ, et al. (2011) MYT1L is a Candidate Gene for Intellectual Disability in Patients With 2p25.3 (2pter) Deletions. Am J Med Genet A 155A: 2739-2745.
10. Kim JG, Armstrong RC, v Agoston D, Robinsky A, Wiese C, et al. (1997) Myelin Transcription Factor 1 (Myt1) of the Oligodendrocyte Lineage, AlongWith a Closely Related CCHC Zinc Finger, Is Expressed in Developing Neurons in the Mammalian Central Nervous System. J Neurosci Res 50: 272-290.
11. Romm E, Nielsen JA, Kim JG, Hudson LD, (2005) Myt1 family recruits histone deacetylase to regulate neural transcription. J Neurochem 93: 1444-1453.
12. Seidl C, Port M, Gilbertz KP, Morgenstern A, Bruchertseifer F, et al. (2007) 213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe. Mol Cancer Ther 6: 2346-2359.
13. Choi HS, Bode AM, Shim J-H, Lee S-Y, Dong Z, (2009) c-Jun N-Terminal Kinase 1 Phosphorylates Myt1 To Prevent UVA-Induced Skin Cancer. Mol Cell Biol 2009 29: 2168-2180.
14. Wang S, Zhang J, Zhao A, Hipkens S, Magnuson MA, et al. (2007) Loss of Myt1 function partially compromises endocrine islet cell differentiation and pancreatic physiological function in the mouse. Mech Dev 124: 898-910.
15. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, et al. (2011) Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 43: 237-241.
16. Zhang Y, Wang M, Gu D, Wu D, Zhang X, et al. (2013) Association of XRCC1 Gene Polymorphisms with the Survival and Clinicopathological Characteristics of Gastric Cancer. DNA Cell Biol 32: 111-118.
17. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, et al. (2006) Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity. J Natl Cancer Inst 98: 1445-1452.
18. Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, et al. (2007) Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 96: 631-638.
19. Kim MA, Lee HS, Yang HK, Kim WH, (2005) Clinicopathologic and Protein Expression Differences between Cardia Carcinoma and Noncardia Carcinoma of the Stomach. Cancer 103: 1439-1446.
20. Wang T, Zeng Z, Li T, Liu J, Li J, et al. (2010) Common SNPs in myelin transcription factor 1-like (MYT1L): association with major depressive disorder in the Chinese Han population. PLoS ONE 5: e13662 doi:10.1371/journal.pone.0013662.
21. Li W, Wang X, Zhao J, Lin J, Song XQ, et al. (2012) Association study of myelin transcription factor 1-like polymorphisms with schizophrenia in Han Chinese population. Genes Brain Behav 11: 87-93.
22. Pagani F, Baralle FE, (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5: 389-396.
23. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
24. Sjakste T, Paramonova N, Grislis Z, Trapina I, Kairisa D, et al. (2011) Analysis of the single-nucleotide polymorphism in the 5′UTR and part of intron I of the sheep MSTN gene. DNA Cell Biol 30: 433-444.
25. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, et al. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuate the p53 tumor suppressor pathway andaccelerates tumor formation in humans. Cell 119: 591-602.
26. Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, et al. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol 24: 4434-4440.
27. Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, et al. (2005) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213-1222.
28. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, (2008) Genetic Risk and Outcome in Psychosis (GROUP) Consortium, Sabatti C, Geurts van Kessel A, Brunner HG, Ophoff RA, Veltman JA. Recurrent CNVs Disrupt Three Candidate Genes in Schizophrenia Patients. Am J Hum Genet 83: 504-510.
29. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, et al. (2010) Replication of association between schizophrenia and ZNF804A in the Irish Case Control Study of Schizophrenia sample. Mol Psychiatry 15: 29-37.
30. Dai X, Yamasaki K, Yang L, Sayama K, Shirakata Y, et al. (2004) Keratinocyte G2/M Growth Arrest by 1,25-Dihydroxyvitamin D3 Is Caused by Cdc2 Phosphorylation Through Wee1 and Myt1 Regulation. J Invest Dermatol 122: 1356-1364.
31. Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, et al. (2003) The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA 100: 2284-2289.
32. Chow JP, Poon RY, (2012) The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery. Oncogene doi: 10.1038/onc.2012.504.